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Abstract
Background: In Uganda, like in many other countries traditionally viewed as harbouring very high malaria transmission, the
norm has been to recommend that febrile episodes are diagnosed as malaria. In this study, the policy implications of such
recommendations are revisited.
Methods: A cross-sectional survey was undertaken at outpatient departments of all health facilities in four Ugandan districts.
The routine diagnostic practices were assessed for all patients during exit interviews and a research slide was obtained for later
reading. Primary outcome measures were the accuracy of national recommendations and routine malaria diagnosis in
comparison with the study definition of malaria (any parasitaemia on expert slide examination in patient with fever) stratified by
age and intensity of malaria transmission. Secondary outcome measures were the use, interpretation and accuracy of routine
malaria microscopy.
Results: 1,763 consultations undertaken by 233 health workers at 188 facilities were evaluated. The prevalence of malaria was
24.2% and ranged between 13.9% in patients ≥5 years in medium-to-high transmission areas to 50.5% for children <5 years in
very high transmission areas. Overall, the sensitivity and negative predictive value (NPV) of routine malaria diagnosis were high
(89.7% and 91.6% respectively) while the specificity and positive predictive value (PPV) were low (35.6% and 30.8% respectively).
However, malaria was under-diagnosed in 39.9% of children less than five years of age in the very high transmission area. At 48
facilities with functional microscopy, the use of malaria slide examination was low (34.5%) without significant differences
between age groups, or between patients for whom microscopy is recommended or not. 96.2% of patients with a routine
positive slide result were treated for malaria but also 47.6% with a negative result.
Conclusion: Current recommendations and associated clinical practices result in massive laria over-diagnosis across all age
groups and transmission areas in Uganda. Yet, under-diagnosis is also common in children <5 years. The potential benefits of
malaria microscopy are not realized. To address malaria misdiagnosis, Uganda's policy shift from presumptive to parasitological
diagnosis should encompass introduction of malaria rapid diagnostic tests and substantial strengthening of malaria microscopy.
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Background
Malaria remains the major public health problem in
Uganda with annual estimates of 10 million cases and
43,000 deaths, of which 91% are in children below 5 years
of age [1]. Malaria transmission has been traditionally
described as stable across 95% of the country, with
approximately two thirds of this area classified as very
high transmission and the rest as medium-to-high trans-
mission [2,3]. Given this epidemiological context, and the
absence of universal coverage of diagnostic services at the
periphery of the health system, presumptive diagnosis of
febrile episodes as malaria and effective treatment has
been the cornerstone of malaria case-management in
Uganda [4].
National malaria diagnosis recommendations for health
workers are outlined in the recent malaria case-manage-
ment guidelines and job aids [4-6], which were revised in
2006 during the implementation of a new malaria treat-
ment policy using artemisinin-based combination ther-
apy (ACT), as the first line anti-malarial. According to
these guidelines any patient presenting with fever or his-
tory of fever in absence of danger signs and prior, correct
use of ACT should be presumptively diagnosed as malaria.
The use of malaria microscopy is discouraged for most
febrile patients with the exception of special patient
groups which include suspected treatment failures, severe
cases, children under 4 months (or below 5 kg) and preg-
nant women.
The malaria diagnostic policy in Uganda is currently
under revision and a more significant role for parasitolog-
ical diagnosis is being considered. In support of the policy
revision process, this study reports on the accuracy of the
current national malaria diagnosis recommendation, the
accuracy of routine malaria diagnosis practices, and eval-
uates the use, interpretation and accuracy of malaria
microscopy at facilities where this diagnostic service is
available.
Methods
Study design and data collection
Between 29 May and 16 August 2007, outpatient malaria
case-management was evaluated at all government and
private not-for-profit health facilities in four Ugandan dis-
tricts (Mubende, Jinja, Tororo and Apac). The survey
methods are described in detail elsewhere [7]. Briefly, the
survey was a cross-sectional, cluster sample survey under-
taken at all facilities in four study districts. Data at each
facility were collected over one day using quality-of-care
assessment methods including health facility assessments,
health worker interviews, and exit interviews with all care-
takers of sick children and adult outpatients seen during
the survey days. Patients coming for follow up visits for
chronic conditions (e.g. TB, diabetes, traumas, burns) and
patients referred or admitted for hospitalization were not
recruited. During the exit interview, study nurses collected
information about the patient's age, weight, temperature,
history of fever, pregnancy status, main complaints, prior
use of anti-malarial drugs, and if the visit was an initial or
follow-up consultation. Information was also collected
from patient-held records about routine diagnostic proce-
dures requested, results reported, and medications pre-
scribed.
In addition, all patients had, on exit, a finger-prick blood
sample taken for malaria microscopy by study laboratory
technicians. Thick and thin blood slides were prepared at
the facility and stained with 10% Giemsa. At post-survey,
two expert microscopists examined independently all
study slides at a laboratory based at Malaria Consortium
in Kampala. For each study slide 100 high-power magni-
fication fields were examined before the slide was
reported as negative. Where results between the two expert
microscopists were discordant, a third microscopist re-
read the blood slide and the majority decision was
accepted as the final result.
Definitions and statistical analysis
The primary analysis focused on 1) the accuracy of fever as
the national malaria diagnosis recommendation, and 2)
the accuracy of routine malaria diagnosis practices. To
reflect national guideline recommendations for presump-
tive malaria diagnosis, the primary analysis was restricted
to non-pregnant patients weighing ≥5 kg, without prior
use of effective anti-malarials, and presenting to the
health facility for an initial, outpatient visit. Fever was
defined as axillary temperature of ≥37.5°C and/or the his-
tory of fever during the present illness. Routine malaria
diagnosis was defined as a patient either diagnosed for
malaria or treated with an anti-malarial drug. This adjust-
ment was done since 8% of patients did not have any
diagnosis written in their cards but all of them had an
anti-malarial prescribed and, therefore, it was obvious
that a malaria diagnosis was considered.
The secondary analysis evaluated the use, interpretation
and accuracy of routine malaria microscopy at health
facilities where this diagnostic service was functional dur-
ing the survey day. The analysis on the use and interpreta-
tion of routine malaria microscopy included all patients at
these facilities. The clinical process was stratified for
patients with and without fever, and subsequently
patients with fever were stratified into those for whom the
guidelines discourage use of microscopy (i.e. recommend
presumptive diagnosis) and those for whom microscopy
is recommended (patients weighing <5 kg, pregnant
women, and those coming for follow up visit or having
prior use of effective anti-malarials). For those patients
who had a routine malaria slide performed, further strati-
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fication was done by the result of the routine malaria test
and the anti-malarial treatment prescribed.
The sensitivity, specificity, positive predictive values
(PPVs) and negative predictive values (NPVs) of the policy
recommendations and current malaria diagnostic prac-
tices were calculated, using standard formulae, against the
study malaria case definition, i.e. the presence of any par-
asitaemia in patients with fever after expert slide examina-
tion. For those patients who had a routine malaria slide
performed, the accuracy of the routine slide result was
evaluated using the same accuracy measures against the
presence of any parasitaemia on expert slide examination.
In all analyses, the precision of proportions (95% confi-
dence interval [CI]) was determined adjusting for the clus-
ter sampling. All analyses were performed across all age
groups and separately for patients below and ≥5 years of
age. The small sample size precluded meaningful compar-
isons between individual districts, thus the results are pre-
sented from all districts and stratified by the two districts
of medium-to-high transmission (Mubende and Jinja:
entomological inoculation rates 4 and 6 respectively) ver-
sus the two districts of very high transmission (Tororo and
Apac: entomological inoculation rates 562 and 1,586
respectively) [2].
All data were double-entered into Microsoft Access 2000
by two independent data entry clerks and data files were
compared for errors by using a verification programme
and referring to original data collection forms. All analy-
ses were performed using STATA, version 9.2 (StataCorp,
College Station, Texas).
Ethical approval
Ethical approval for this study was provided by the
Uganda National Council for Science and Technology
(reference number HS 275).
Results
Sample description
In total, 1,763 outpatient consultations undertaken by
233 health workers at 188 health facilities were evaluated.
Of 1,763 patients, 278 patients were excluded from the
primary analysis evaluating accuracy of malaria diagnosis
recommendations and routine malaria diagnosis because
they either did not meet the inclusion criterion (n = 274)
or had missing results for expert slide examination (n = 4).
Therefore, this analysis included 1,485 patients, of which
494 (33.3%) were children below five years of age and
991 (66.7%) were patients five years and older. Of 1,485
patients, 907 were evaluated in the medium-to-high trans-
mission intensity districts (Mubende and Jinja) and 578
in the very high transmission intensity districts (Tororo
and Apac). Children below five years of age comprised
288 (31.8%) patients in the medium-to-high and 206
(35.6%) in the very high transmission intensity districts.
For the secondary analysis, the routine clinical process
was evaluated from 473 consultations undertaken by 70
health workers at 48 health facilities with functional
microscopy on the survey day (26% of all facilities). There
were 149 (31.5%) observations for children below five
years of age and 324 (68.5%) for patients five years and
older. Among all patients 163 routine malaria slides were
performed, for which five (3%) expert slide results were
not available. Therefore, the accuracy of the routine
malaria microscopy was evaluated on 158 slides, of which
48 (30.4%) were for children below five years of age and
110 (69.6%) were for patients ≥5 years of age.
Background prevalence of key parameters in the study
Table 1 presents results on the background prevalence of
malaria parasitaemia, malaria disease, fever, and routine
malaria diagnosis stratified by age and malaria transmis-
sion area. Of the 1,485 patients meeting our inclusion cri-
teria for primary analysis (non-pregnant patients,
weighing ≥5 kg, without prior use of effective anti-malari-
als, and presenting for an initial, outpatient visit), the
overall prevalence of malaria parasitaemia present by
expert microscopy was 27.8%. Overall and across both
transmission settings, children below five years of age
were more commonly parasitaemic than patients five
years and older. The prevalence of malaria parasitaemia
ranged from 16.8% in patients ≥5 years of age in medium-
to-high transmission area to as high as 53.9% in children
below five years of age in very high transmission area. The
prevalence of malaria disease according to the study defi-
nition (presence of any parasitaemia by expert slide exam-
ination in a patient with fever) was only marginally lower
than any parasitaemia (overall 24.2%) and ranged across
all categories from 13.9% in patients five years and older
in medium-to-high transmission areas to 50.5% for chil-
dren in very high transmission areas (Table 1).
Conversely, the overall prevalence of fever was high
(79.2%) and was significantly higher in children under
five years (88.7%) than in patients five years and older
(74.5%). The higher prevalence of fever was observed in
very high transmission areas (82.5%) compared to
medium-to-high transmission areas (77.1%), however
the difference was not statistically significant (Table 1).
Equally, routine malaria diagnosis was commonly made
and largely mirrored the age and transmission patterns of
fever (Table 1). Overall, of the 1,485 patients evaluated,
70.5% were diagnosed for malaria, more frequently in
children below five years of age (78.5%) compared to
patients five years and older (66.5%). No statistically sig-
nificant difference was observed between medium-to-
high and very high malaria transmission areas, neither
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across all age groups (73.2% vs 68.8%) nor within partic-
ular age categories (82.5% vs 75.7% in children below five
and 68.0% vs 65.6% in patients ≥5 years of age).
Accuracy of policy recommendations and routine malaria 
diagnosis
The malaria case-management policy recommending pre-
sumptive diagnosis of fever as malaria had high sensitivity
and NPV (by our definition 100%), however, the specifi-
city and PPV of these recommendations were very low
(27.4% and 30.5% respectively) across both age groups
and transmission settings (Table 2). The magnitude of
malaria over-diagnosis (1-PPV) differed between trans-
mission settings and age groups, ranging from the lowest,
45.3% in children below five years of age in very high
transmission area, to as high as 80.9% in patients ≥5 years
of age in medium-to-high transmission area.
In comparison to the accuracy of national case-manage-
ment recommendations, routine malaria diagnostic prac-
tices of health workers resulted in somewhat higher
specificity (35.6% vs 27.4%) and lower sensitivity (89.7%
vs 100%) (Table 3). The over-diagnosis rates (1-PPV) of
routine malaria diagnosis were similar to those of
national recommendations and they ranged from 47.1%
to 80.5% across all categories. Importantly, routine
malaria diagnostic practices had higher rates of malaria
under-diagnosis (1-NPV) compared to national recom-
mendations and they ranged from the lowest 3.3% in
patients = 5 years of age in medium-to-high transmission
area to as high as 39.9% in children below five years of age
in very high transmission area (Table 3).
Use, interpretation and accuracy of routine malaria 
microscopy
Of the 473 patients at facilities with functional micros-
copy, 342 (72.3%) presented with fever and 131 (27.7%)
without fever. Among the patients with fever, there were
57 for whom the national guidelines recommend the use
of microscopy, while the remaining 285 febrile patients
Table 1: Background prevalence of malaria parasitaemia, malaria disease, fever, and routine malaria diagnosis, stratified by 
transmission intensity and age categories
Very high transmission districts
n,% (95% CI)
Moderate-to high transmission districts
n,% (95% CI)
All districts
n,% (95% CI)
All age groups N = 578 N = 907 N = 1485
Malaria parasitaemia 203, 35.1 (31.0–39.3) 210, 23.2 (19.9–26.4) 413, 27.8 (25.0–30.6)
Malaria disease* 175, 30.3 (26.3–34.3) 184, 20.3 (17.1–23.5) 359, 24.2 (21.5–26.8)
Fever prevalence 477, 82.5 (78.6–86.5) 699, 77.1 (73.6–80.5) 1176, 79.2 (76.6–81.8)
Routine malaria diagnosis 423, 73.2 (68.1–78.3) 624, 68.8 (64.0–73.6) 1047, 70.5 (67.0–74.1)
Patients <5 years N = 206 N = 288 N = 494
Malaria parasitaemia 111, 53.9 (48.6–59.2) 106, 36.8 (29.6–44.0) 217, 43.9 (39.0–48.9)
Malaria disease* 104, 50.5 (44.9–56.1) 98, 34.0 (26.8–41.2) 202, 40.9 (35.9–45.9)
Fever prevalence 190, 92.2 (88.2–96.3) 248, 86.1 (82.2–90.0) 438, 88.7 (85.8–91.5)
Routine malaria diagnosis 170, 82.5 (76.3–88.8) 218, 75.7 (69.8–81.6) 388, 78.5 (74.2–82.8)
Patients ≥5 years N = 372 N = 619 N = 991
Malaria parasitaemia 92, 24.7 (20.1–29.3) 104, 16.8 (13.7–19.9) 196, 19.8 (17.1–22.4)
Malaria disease* 71, 19.1 (15.2–23.0) 86, 13.9 (10.9–16.9) 157, 15.8 (13.5–18.2)
Fever prevalence 287, 77.2 (71.6–82.7) 451, 72.9 (68.3–77.4) 738, 74.5 (71.0–78.0)
Routine malaria diagnosis 253, 68.0 (61.8–74.2) 406, 65.6 (60.0–71.2) 659, 66.5 (62.3–70.7)
* Defined as any malaria parasitaemia on expert slide examination in patient with fever
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were cases for whom malaria microscopy is discouraged.
Among all patients (473), the overall use of routine
malaria microscopy was low (34.5%; 95% CI: 23.4–45.6)
and there were no differences in microscopy use between
children below five years of age (50/149; 33.6%; 95% CI:
21.4–45.7) and patients five years and older (113/324;
34.9%; 95% CI: 23.0–46.8). Patients for whom guidelines
recommend the use of microscopy were more frequently
routinely tested (45.6%; 95% CI: 28.4–62.9) than the
patients with fever for whom microscopy is discouraged
(39.5%; 95% CI: 27.4–51.5) and patients without fever
(28.4%; 95% CI: 9.8–33.0), however the differences
between these categories of patients were not statistically
significant.
Overall, there were 79 positive and 84 negative slides rou-
tinely reported. Nearly all patients with a positive slide
result were treated for malaria (96.2%; 95% CI: 91.8–
100). Yet, health workers prescribed an anti-malarial
treatment for 47.6% (95% CI: 31.3–64.0) of patients with
a routinely reported negative slide result. Conversely,
health workers respected a negative test result and did not
prescribe an anti-malarial for 52.4% (95% CI: 36.0–68.7)
of patients. Among patients with fever, 58.1% (95% CI:
37.3–78.8) with a negative test result were treated with an
anti-malarial, the proportion being higher in children
below five years of age (19/26; 73.1%; 95% CI: 50.3–
95.8) than in patients five years and older (17/36; 47.2%;
95% CI: 21.5–73.0).
Table 4 shows the results on the accuracy of routine read-
ing of malaria slides for 158 patients for whom the match-
ing slide result of the expert microscopy was available. The
expert slide positivity rate was only 18.4%, significantly
lower compared to the routine slide positivity rate
(49.4%). Although the sample size was small, in this sub-
set of patients the expert microscopy suggested similar
positivity rates between areas of medium-to-high (6/32;
18.8%) and very high transmission areas (23/126;
18.3%). The sensitivity and the specificity of the routine
blood slide readings were 58.6% and 52.7%, respectively.
The PPV was very low (21.8%) while the NPV was high
(85.0%). Although not statistically significant, differences
in predictive values were suggested between age groups:
the respective PPVs for children below five years and
patients five years and older were 45.0% and 13.8%, while
the NPVs in the same age groups were 71.4% and 92.3%,
respectively (Table 4).
Discussion
These facility-based data stratified by age and transmis-
sion intensity reveal a series of important findings directly
relevant for the revision of malaria diagnostic recommen-
dations within the context of deployment of new ACT pol-
icies in Uganda.
First, the prevalence of malaria parasitaemia among most
outpatient groups was lower than initially expected.
Indeed, across different transmission settings, which are
Table 2: Specificity and positive predictive value (PPV) of fever as policy recommendations compared with malaria disease*, stratified 
by transmission intensity and age categories
Very high transmission districts
n/N,% (95% CI)
Moderate-to-high transmission districts
n/N,% (95% CI)
All districts
n/N,% (95% CI)
All age groups
Specificity 101/403, 25.1 (19.7–30.5) 208/723, 28.8 (24.7–32.9) 309/1126, 27.4 (24.2–30.7)
PPV 175/477, 36.7 (32.1–41.3) 184/699, 26.3 (22.4–30.3) 359/1176, 30.5 (27.4–33.6)
Patients <5 years
Specificity 16/102, 15.7 (7.9–23.4) 40/190, 21.1 (15.8–26.3) 56/292, 19.2 (14.9–23.5)
PPV 104/190, 54.7 (49.1–60.4) 98/248, 39.5 (31.8–47.3) 202/438, 46.1 (41.0–51.3)
Patients ≥5 years
Specificity 85/301, 28.2 (21.7–34.7) 168/533, 31.5 (26.4–36.6) 253/834, 30.3 (26.4–34.3)
PPV 71/287, 24.7 (20.0–29.5) 86/451, 19.1 (15.1–23.0) 157/738, 21.3 (18.2–24.3)
* Defined as any malaria parasitaemia on expert slide examination in patient with fever
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Table 3: Accuracy of routine malaria diagnosis compared with malaria disease*, stratified by transmission intensity and age categories
Very high transmission districts
n/N,% (95% CI)
Moderate-to-high transmission districts
n/N,% (95% CI)
All districts
n/N,% (95% CI)
All age groups
Sensitivity 150/175, 85.7 (79.6–91.8) 172/184, 93.5 (89.9–97.1) 322/359, 89.7 (86.1–93.3)
Specificity 130/403, 32.3 (26.4–38.1) 271/723, 37.5 (32.1–42.9) 401/1126, 35.6 (31.6–39.6)
PPV 150/423, 35.5 (30.8–40.1) 172/624, 27.6 (23.4–31.8) 322/1047, 30.8 (27.6–34.0)
NPV 130/155, 83.9 (77.8–90.0) 271/283, 95.8 (93.6–97.9) 401/438, 91.6 (88.7–94.4)
Patients <5 years
Sensitivity 90/104, 86.5 (79.7–93.4) 93/98, 94.9 (90.6–99.2) 183/202, 90.6 (86.4–94.8)
Specificity 22/102, 21.6 (12.6–30.5) 65/190, 34.2 (26.7–41.7) 87/292, 29.8 (24.0–35.6)
PPV 90/170, 52.9 (46.6–59.3) 93/218, 42.7 (34.4–50.9) 183/388, 47.2 (41.8–52.6)
NPV 22/36, 61.1 (45.8–76.4) 65/70, 92.9 (86.9–98.8) 87/106, 82.1 (74.5–89.7)
Patients ≥5 years
Sensitivity 60/71, 84.5 (75.2–93.9) 79/86, 91.9 (86.1–97.6) 139/157, 88.5 (83.3–93.7)
Specificity 108/301, 35.9 (29.3–42.4) 206/533, 38.7 (32.7–44.6) 314/834, 37.7 (33.2–42.1)
PPV 60/253, 23.7 (18.4–29.0) 79/406, 19.5 (15.4–23.5) 139/659, 21.1 (17.9–24.3)
NPV 108/119, 90.8 (85.8–95.7) 206/213, 96.7 (94.5–99.0) 314/332, 94.6 (92.2–96.9)
* Defined as any malaria parasitaemia on expert slide examination in patient with fever
Table 4: The slide positivity rate and accuracy of routine malaria microscopy compared to expert microscopy, stratified by age 
categories
Patients <5 years
n/N,% (95% CI)
Patients ≥5 years
n/N,% (95% CI)
All patients
n/N,% (95% CI)
Slide positivity rate
(routine microscopy)
20/48, 41.7 (25.7–57.5) 58/110, 52.7 (38.8–66.7) 78/158, 49.4 (36.7–62.1)
Slide positivity rate
(expert microscopy)
17/48, 35.4 (21.2–49.6) 12/110, 10.9 (4.8–17.0) 29/158, 18.4 (12.5–24.2)
Sensitivity 9/17, 52.9 (24.2–81.7) 8/12, 66.7 (35.6–97.7) 17/29, 58.6 (38.4–78.9)
Specificity 20/31, 64.5 (44.7–84.3) 48/98, 49.0 (34.6–63.3) 68/129, 52.7 (39.2–66.2)
PPV 9/20, 45.0 (18.3–71.7) 8/58, 13.8 (4.7–22.9) 17/78, 21.8 (11.0–32.6)
NPV 20/28, 71.4 (53.5–89.3) 48/52, 92.3 (84.8–99.8) 68/80, 85.0 (78.9–91.1)
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all traditionally viewed as high malaria transmission
intensity areas, only 17–25% of patients above five years
of age were parasitaemic. The prevalence rate of 44% was
higher in children below five years of age; however, this
rate did not exceed 54% even in the areas historically
described as having the highest EIRs in the world with
between 564 and 1,564 infective bytes per person per year
[2] and community-based childhood malaria prevalence
rates as high as 79–91% [8]. However, the comparisons
between community and facility-based prevalence rates
are not straightforward. Intuitively, prevalence rates
among sick outpatients can be expected to be at least sim-
ilar, if not higher, compared to those obtained from
household surveys among healthy populations. The self-
selection of populations presenting to facilities, who may
have higher socio-economic status or different health-
seeking behaviour may provide some explanation to this
pattern [9,10]. Nevertheless, the findings in this study sug-
gest that in nearly all studied populations, the majority of
patients present to outpatient facilities without malaria
parasitaemia.
Second, given the low prevalence of malaria (24%), high
frequency of fever among outpatients (79%), and health
workers' practices largely reflecting recommendations
promoting presumptive malaria diagnosis for all febrile
patients, the current rates of outpatient malaria over-diag-
nosis in Uganda are massive, reaching as high as 79% for
patients five years and older and remaining high even in
the children below five years of age in the study areas of
highest malaria transmission (47%). The over-diagnosis
rates of routine practices were not much lower than 75%
previously reported rates from an area of low and unstable
malaria transmission in western Uganda [11].
Yet, it was worrying to observe that despite the minimum
overall deviations from national diagnosis recommenda-
tions, the current practices in very high transmission areas
resulted in a large proportion (49%) of children below
five years of age who are not diagnosed although parasi-
taemic and subsequently not treated for malaria. As
observed repeatedly in many studies in the past two dec-
ades across Africa [12-16], any deviation from the case
definition equalizing fever with malaria increases the spe-
cificity of malaria diagnosis, however at the cost of sub-
stantially decreased sensitivity. This inevitably results in
malaria under-diagnosis, the magnitude of which is
dependent on the background prevalence of the disease.
The under-diagnosis rates observed in this study present
an unacceptable trade-off in children, the population
most vulnerable to severe and potentially fatal malaria
complications. Therefore, the only potential solution to
circumvent problems of malaria misdiagnosis (both over-
and under-diagnosis) in Uganda is the change of diagnos-
tic policy from presumptive to parasitological diagnosis of
malaria and systematic use of malaria tests for all febrile
patients by performing reliable malaria microscopy and
introducing rapid diagnostic tests (RDTs).
Finally, a shift from the current presumptive policy based
on fever to an effective policy based on malaria diagnos-
tics is unlikely to be trivial. The findings at facilities with
functional microscopy in study districts suggest that: 1)
febrile patients are not sufficiently tested regardless of
whether testing is recommended (46%) or discouraged by
guidelines (38%), and 2) there is an overwhelming ten-
dency to ignore negative slide results and prescribe anti-
malarial drugs (58%). The underuse of malaria micros-
copy and the prescription of anti-malarials for negative
test results revealed in this study mirror well-described
patterns of microscopy use and results interpretation
reported in past studies in Kenya [17], Zambia [18,19]
and Tanzania [20,21]. With respect to the routine labora-
tory performance, the quality of routine malaria slide
reading was poor (sensitivity and specificity below 60%)
and characterized by substantial over-reporting of positive
slides across all age groups (55–86%), however, most of
the results routinely reported as negative were truly nega-
tive, more commonly in patients five years and older
(93%) than in children below five years of age (71%).
While 29% of false negative results might offer justifica-
tion for the treatment of test negative children, the find-
ings in patients five years and older are in obvious
discordance with prescription practices where nearly all
positive tests are routinely treated but also 47% of patients
with negative tests. This irrational practice of overruling
negative test results, and still performing malaria tests,
may have multiple causes but an important one stems out
from the decades of ambiguous recommendations trans-
lated into pre-service and in-service training programmes
and routine practice where malaria microscopy has been
seen as a tool to confirm clinical suspicion but rarely as a
tool to rule out malaria diagnosis [22,23]. Despite the
problems of ensuring large-scale quality of routine micro-
scopy-based malaria case-management across Africa,
recent, smaller-scale studies suggest that intensive inter-
ventions including at least five days long, integrated in-
service training for clinical and laboratory staff supported
with supervision and strengthened surveillance may
improve some aspects of microscopy-based malaria case-
management [24,25]. The challenge remains defining
most cost-effective components of such interventions,
their routine scale up and maintenance to ensure long-
term performance at all facilities providing microscopy
services.
The Ugandan Ministry of Health should be commended
for the current revisions of malaria diagnostic policies to
promote greater access to parasitological-based diagnosis.
An important component of this is the introduction of
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malaria RDTs to complement microscopy specifically in
health facilities without laboratory services. Malaria RDTs
are accurate under controlled conditions, easy to use and
interpret, provide rapid results, and can be performed
with the minimum of training and equipment. Yet, the
success of this diagnostic strategy encompassing RDTs will
be critically dependent on ensuring high accuracy (in par-
ticular sensitivity) of RDTs under field conditions
[11,26,27], and ensuring a radical change of health work-
ers current practices with emphasis on systematic screen-
ing of all fevers, respect of test negative results, and
capacity building to manage non-malarial fevers. A qual-
ity assurance process at national and peripheral level;
development, validation and distribution of clear clinical
guidelines to address malaria and non-malaria fevers;
health workers', preferably on-job training to introduce
tests, initiate translation of guidelines into practice, but
also to solve local obstacles to implement microscopy and
RDTs; and frequent effective supervision to maintain
good practices are the minimum pre-requisites for the suc-
cess of such a strategy. Therefore, it is important that the
introduction of RDTs is accompanied by similar activities
to strengthen the quality of microscopy, either as a sepa-
rate preliminary activity or as an activity integrated within
the RDT implementation process [28].
Finally, prior to the national policy change and scale-up,
it would be wise that the implementation package intro-
ducing RDTs and strengthening malaria microscopy is
piloted at district-level in areas of different malaria ende-
micity. Such pilots should include an operational research
component which should monitor routine health work-
ers' practices and real-world accuracy of both diagnostic
tools, and evaluate cost and health benefits of a parasito-
logical-based diagnostic strategy in particular compared
with the presumptive treatment strategy in the most vul-
nerable groups such as children below five years of age.
The lessons learned from these pilots should help policy
makers to improve upon implementation delivery and
take informed decisions if all age groups and transmission
settings should be the targets of parasitological-based
diagnosis for the national scale-up. Failing to approach
the introduction of this new diagnostic tool in a careful
and evidence-based manner will mean that no lessons
have been learned from the experiences of implementing
malaria microscopy.
Conclusion
The traditional view of Uganda as a very high malaria
endemic area where most of fevers are due to malaria is
unlikely to be true. A large majority of outpatients, across
all age groups and transmission areas, with the exception
of children below five years of age in very high transmis-
sion areas, do not have malaria parasitaemia. National
recommendations promoting presumptive malaria diag-
nosis for all patients with fever and health workers prac-
tices following these recommendations result in massive
over-diagnosis, particularly in patients five years and
older. Equally important, in children below five years of
age in very high transmission areas, the current practices
result in substantial malaria under-diagnosis. The prob-
lem of malaria misdiagnosis can only be tackled by using
parasitological-based malaria diagnosis, however, the cur-
rent experiences of malaria microscopy in Uganda suggest
that the potential benefits are not realized because of the
poor quality of routine reading of slides and irrational
clinical practices. There is need for the change of policy
from presumptive to parasitological-based diagnosis,
however, the modalities of this change and real-world
effectiveness of this strategy will be critically dependent
on the quality, and coverage, of the implementation proc-
ess which must be accompanied by a strong operational
research component.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
JN and DZ contributed to study design, data analysis and
interpretation of results. JNN contributed to data analysis
and interpretation of results. JBR and HC contributed to
study design, interpretation of results and policy implica-
tions of the findings. RWS and JKT contributed to the con-
ception and design of the study, and interpretation of
results. All authors contributed to drafting of the manu-
script and all read and approved the final manuscript.
Acknowledgements
This study received financial support from the COMDIS Research Pro-
gramme Consortium funded by the Department for International Develop-
ment, UK through the Malaria Consortium. RW Snow is a Wellcome Trust 
Principal Research Fellow (#079080). The authors are grateful to Moses 
Musinguzi who supervised field work at its initial stages, James Ssekitoleeko 
who supervised the data entry, Ambrose Talisuna for the technical support 
during the study, district health authorities of study districts, the field teams 
and to all health workers, patients, and caretakers of sick children who par-
ticipated in the study. The authors are also grateful to Mike English for com-
ments on an earlier draft.
References
1. World Health Organization (WHO): World Malaria Report 2008 2008.
2. Okello PE, Van Bortel W, Byaruhanga AM, Correwyn A, Roelants P,
Talisuna A, D'Alessandro U, Coosemans M: Variation in malaria
transmission intensity in seven sites throughout Uganda.  Am
J Trop Med Hyg 2006, 75:219-225.
3. Hopkins H, Bebell L, Kambale W, Dokomajilar C, Rosenthal PJ, Dor-
sey G: Rapid diagnostic tests for malaria at sites of varying
transmission intensity in Uganda.  J Infect Dis 2008, 197:510-518.
4. Republic of Uganda: Management of uncomplicated malaria: a practical
guide for health workers Malaria Control Programme, Ministry of
Health; 2005. 
5. Republic of Uganda: Flowchart for management of malaria Malaria Con-
trol Programme, Ministry of Health; 2005. 
6. Republic of Uganda: Integrated management of childhood illnesses Minis-
try of Health; 2007. 
Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Malaria Journal 2009, 8:66 http://www.malariajournal.com/content/8/1/66
Page 9 of 9
(page number not for citation purposes)
7. Zurovac D, Tibenderana JK, Nankabirwa J, Ssekitooleko J, Njogu JN,
Rwakimari JB, Meek S, Talisuna A, Snow RW: Malaria case-man-
agement under artemether-lumefantrine treatment policy
in Uganda.  Malar J 2008, 7:181.
8. Talisuna AO, Langi P, Bakyaita N, Egwan T, Mutabingwa TK, Watkins
W, Van Marck E, D'Alessandro U: Intensity of malaria transmis-
sion, antimalarial-drug use and resistance in Uganda: what is
the relationship between these three factors?  Trans R Soc Trop
Med Hyg 2002, 96:310-317.
9. Kiwanuka SN, Ekirapa EK, Peterson S, Okui O, Rahman MH, Peters
D, Pariyo GW: Access to and utilisation of health services for
the poor in Uganda: a systematic review of available evi-
dence.  Trans R Soc Trop Med Hyg 2008, 102:1067-1074.
10. Byass P: Making sense of long term changes in malaria.  Lancet
2008, 372:1523-1525.
11. Ndyomugenyi R, Magnussen P, Clarke S: Diagnosis and treatment
of malaria in peripheral health facilities in Uganda; fidings
from an area of low transmission in south-western Uganda.
Malar J 2007, 6:39.
12. Rooth I, Bjorkman A: Fever episodes in a holoendemic malaria
area of Tanzania: parasitological and clinical findings and
diagnostic aspects related to malaria.  Trans R Soc Trop Med Hyg
1992, 86:479-482.
13. Redd SC, Kazembe PN, Luby SP, Nwanyanwu O, Hightower AW,
Ziba C, Wirima JJ, Chitsulo L, Franco C, Olivar M: Clinical algo-
rithm fortreatment of Plasmodium falciparum malaria in chil-
dren.  Lancet 1996, 347:223-227.
14. Marsh K, English M, Peshu N, Crawley J, Snow RW: Clinical algo-
rithm for malaria in Africa.  Lancet 1996, 347:1327-1328.
15. Chandramohan D, Jaffar S, Greenwood BM: Use of clinical algo-
rithms for diagnosing malaria.  Trop Med Int Health 2002, 7:45-52.
16. Mwangi TW, Mohammed M, Dayo H, Snow RW, Marsh K: Clinical
algorithms for malaria diagnosis lack utility among people of
different age groups.  Trop Med Int Health 2005, 10:530-536.
17. Zurovac D, Njogu J, Akhwale W, Hamer DH, Larson BA, Snow RW:
Effects of revised diagnostic recommendations on malaria
treatment practices across age groups in Kenya.  Trop Med Int
Health 2008, 13:784-787.
18. Barat L, Chipipa J, Kolczak M, Sukwa T: Does availability of blood
slide microscopy for malaria at health centres improve the
management of persons with fever in Zambia.  Am J Trop Med
Hyg 1999, 60:1024-1030.
19. Hamer DH, Ndhlovu M, Zurovac D, Fox M, Yeboah-Antwi K, Chanda
P, Sipilinyambe N, Simon LJ, Snow RW: Improved diagnostic test-
ing and malaria treatment practices in Zambia.  JAMA 2007,
297:2227-2231.
20. Reyburn H, Mbakilwa H, Mwangi R, Mwerinde O, Olomi R, Drakeley
C, Whitty CJM: Rapid diagnostic tests compared with malaria
microscopy for guiding outpatient treatment of febrile ill-
ness in Tanzania: randomised trial.  BMJ 2007, 334:403.
21. Chandler CI, Chonya S, Boniface G, Juma K, Reyburn H, Whitty CJ:
The importance of context in malaria diagnosis and treat-
ment decisions – a quantitative analysis of observed clinical
encounters in Tanzania.  Trop Med Int Health 2008, 13:1131-1142.
22. Zurovac D, Midia B, Ochola SA, English M, Snow RW: Microscopy
and outpatient malaria case management among older chil-
dren and adults in Kenya.  Trop Med Int Health 2006, 11:432-440.
23. Chandler CIR, Jones C, Boniface G: Guidelines and mindlines:
Why do clinical staff over-diagnose malaria in Tanzania?
Malar J 2008, 7:53.
24. Ssekabira U, Bukirwa H, Hopkins H, Namagembe A, Weaver MR,
Sebuyira LM, Quick L, Staedke S, Yeka A, Kiggundu M, Schneider G,
McAdam K, Wabwire-Mangen F, Dorsey G: Improved malaria
case management after integrated team-based training of
health Care workers in Uganda.  Am J Trop Med Hyg 2008,
79:826-833.
25. Ngasala B, Mubi M, Warsame M, Petzold MG, Massele AY, Gustafsson
LL, Tomson G, Premji Z, Bjorkman A: Impact of training in clini-
cal and microscopy diagnosis of childhood malaria on anti-
malarial drug prescription and health outcome at primary
health care level in Tanzania: A randomized controlled trial.
Malar J 2008, 7:199.
26. McMorrow ML, Masanja MI, Abdulla SM, Kahigwa E, Kachur SP: Chal-
lenges in routine implementation and quality control of
rapid diagnostic tests for malaria-Rufiji District, Tanzania.
Am J Trop Med Hyg 2008, 79(3):385-390.
27. Endeshaw T, Gebre T, Ngondi J, Graves PM, Shargie EB, Ejigsemahu
Y, Ayele B, Yohannes G, Teferi T, Messele A, Zerihun M, Genet A,
Mosher AW, Emerson PM, Richards FO: Evaluation of light
microscopy and rapid diagnostic test for the detection of
malaria under operational field conditions: a household sur-
vey in Ethiopia.  Malar J 2008, 7:118.
28. Williams HA, Causer L, Metta E, Malila A, O'Reilly T, Abdulla S,
Kachur SP, Bloland PB: Dispensary level pilot implementation
of rapid diagnostic tests: an evaluation of RDT acceptance
and usage by providers and patients – Tanzania, 2005.  Malar
J 2008, 7:239.
